Salient Capital Advisors’s Cartesian Growth Corporation II Unit RENEU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,000
Closed -$251K 90
2022
Q2
$251K Buy
+25,000
New +$250K 0.01% 67

Other funds holding RENEU

Salient Capital Advisors's RENEU Position: Q3 2022 in Review

Salient Capital Advisors sold out of Cartesian Growth Corporation II Unit (RENEU) in Q3 2022, closing a stake of 25,000 shares — an estimated $251K sold.

Salient Capital Advisors first reported a position in RENEU in Q2 2022 and held it in 1 quarter. The position peaked at $251K in Q2 2022. 18 funds tracked by Wall St. Rank hold RENEU as of Q3 2022.

  • Salient Capital Advisors reported no remaining Cartesian Growth Corporation II Unit position as of Q3 2022 after selling out during the quarter.
  • Salient Capital Advisors sold 25,000 Cartesian Growth Corporation II Unit shares in Q3 2022, an estimated $251K.
  • Salient Capital Advisors first reported a position in Cartesian Growth Corporation II Unit in Q2 2022 and held it in 1 quarter.
  • Salient Capital Advisors's Cartesian Growth Corporation II Unit position peaked at $251K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Cartesian Growth Corporation II Unit as of Q3 2022.

Based on Salient Capital Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.